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Abstract
Rheumatoid arthritis (RA) is characterized by synovial
hyperplasia and destruction of cartilage and bone. The
fibroblast-like synoviocyte (FLS) population is central to the
development of pannus by migrating into cartilage and bone.
We demonstrated previously that expression of the cell cycle
inhibitor p21 is significantly reduced in RA synovial lining,
particularly in the FLS. The aim of this study was to determine
whether reduced expression of p21 in FLS could alter the
migratory behavior of these cells. FLS were isolated from mice
deficient in p21 (p21(-/-)) and were examined with respect to
growth and migration. p21(-/-) and wild-type (WT) FLS were
compared with respect to migration towards chemoattractants
found in RA synovial fluid in the presence and absence of cell
cycle inhibitors. Restoration of p21 expression was
accomplished using adenoviral infection. As anticipated from
the loss of a cell cycle inhibitor, p21(-/-) FLS grow more rapidly
than WT FLS. In examining migration towards biologically
relevant RA synovial fluid, p21(-/-) FLS display a marked increase
(3.1-fold; p < 0.05) in migration compared to WT cells.
Moreover, this effect is independent of the cell cycle since
chemical inhibitors that block the cell cycle have no effect on
migration. In contrast, p21 is required to repress migration as
restoration of p21 expression in p21(-/-) FLS reverses this effect.
Taken together, these data suggest that p21 plays a novel role
in normal FLS, namely to repress migration. Loss of p21
expression that occurs in RA FLS may contribute to excessive
invasion and subsequent joint destruction.
Introduction
Proper regulation of the mammalian cell cycle is vital for cellu-
lar homeostasis. Alterations in the cell cycle components have
been associated with several disease states. Progression
through the different phases of the cell cycle is dependent on
the activities of cyclin dependent kinases (cdks) bound to their
cognate cyclins [1,2]. Another level of cell cycle regulation is
affected by the cdk inhibitors, which bind to cdk or cdk-cyclin
complexes and inhibit their kinase activity. The cdk inhibitors
are grouped into two categories based on homology and pref-
erential cdk-cyclin binding (Inks, comprising p15, p16, p18
and p19; and Cip/Kip, comprising p21, p27 and p57). Over-
expression of any of the cdk inhibitors will induce G1-cell cycle
arrest [3]. Deficiencies in p16 [4,5], p18 [6], p19 [7,8], p27
[6,9-11] and p21 [12,13] may lead to or enhance oncogene-
sis. However, to date, only the loss of p21 has been associ-
ated with the development of an autoimmune disease
phenotype [14,15]. New unexpected roles for p21 and p27
have recently been revealed in apoptosis and transcriptional
activation [16]. Moreover, p27 has been found to play a novel
role in regulating cell migration, where fibroblasts lacking p27
exhibit dramatically decreased motility in comparison with con-
trols [17].
Rheumatoid arthritis (RA) is a chronic inflammatory and
destructive disease [18]. The fibroblast-like synoviocytes
(FLS) that comprise the synovial lining, a thin membrane in
direct contact with cartilage and bone, are one of the principal
AdlacZ = adenovirus expressing β-galactosidase; Adp21 = adenovirus expressing p21; bFGF = basic fibroblast growth factor; cdk = cyclin-depend-
ent kinase; DMEM = Dulbecco's modified Eagle's medium; FBS = fetal bovine serum; FLS = fibroblast-like synoviocytes; Gax = growth-arrest specific 
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cells responsible for the pathogenesis of RA. In RA, the FLS
increase in number and produce pro-inflammatory cytokines,
chemokines, and matrix-metalloproteinases that promote
inflammation and joint destruction. Isolated RA FLS induce
arthritis when transferred to the knees of healthy SCID mice in
the absence of a functional immune system [19]. Recently, the
role of p21 in the pathogenesis of RA has been investigated.
The expression of p21 is reduced in RA when compared to
osteoarthritis synovial tissue [20], particularly in the FLS pop-
ulation. Overexpression of p21 inhibits proliferative and inflam-
matory properties in FLS isolated from patients with RA [20-
24] and results in the amelioration of experimental arthritis in
mice and rats [21-24]. These data demonstrate that p21 nor-
mally functions to inhibit the inflammatory response in FLS.
Herein, we investigate the role of p21 in modulating the migra-
tion of FLS. Our data suggest that p21 normally represses
migration in FLS and that loss of p21 expression that occurs
in RA may contribute to excessive invasion by FLS.
Materials and methods
Mouse synovial fibroblasts
p21(-/-)  (B6;129S2-Cdkn1atm1Tyj/J) and wild-type (WT;
B6;129SF2/J) mice were purchased from the Jackson Labo-
ratory (Bar Harbor, Maine, USA). Mouse knees were excised
from WT or p21(-/-) mice and pooled. Isolated mouse synovial
tissues were digested with collagenase, dispase, and DNAse
I, and single cell suspensions were obtained [20,25,26]. A
homogenous population was determined by flow cytometry
(<1% CD11b, <1% F4/80, and <1% CD45). FLS were cul-
tured in a standard DMEM + 10% FBS (Hyclone Inc., Logan,
UT, USA) with penicillin/streptomycin. FLS were used at pas-
sage ≥3, at which time cells were considered to be a more
homogeneous population of fibroblasts. All mouse studies
were performed with Animal Care and Use Committee
approval at St Louis University.
Patient samples
Synovial fluid (SF) specimens were collected during arthro-
centesis from patients who met the American College of Rheu-
matology criteria for a diagnosis of RA. All specimens were
obtained with approval of Midwestern University's Institutional
Review Board.
FLS proliferation
WT and p21(-/-) fibroblasts were plated at 1.8 × 104 cells/well
in 1 ml DMEM + 10% FBS in a standard 24-well tissue culture
plate and incubated at 37°C. At different time points cells
were washed with PBS, trypsinized and their number quanti-
fied by hemocytometer counts with trypan blue. Analysis was
performed in triplicate wells and results are expressed as the
mean ± standard error (SE).
Chemotaxis and checkerboard assays with RA synovial 
fluid
Chemotaxis was performed with minor modifications to a pro-
tocol previously optimized for RA synoviocyte chemotaxis [27].
WT and p21(-/-) FLS were cultured for 18 h in DMEM contain-
ing 1% FBS. One hour prior to the assay, this media was
removed, cells were rinsed twice with PBS, and media was
replaced with DMEM containing 0.1% FBS. FLS (2.6 × 104
cells/well in DMEM + 0.1% FBS) with or without mitomycin C
(MMC; 10 µg/ml; Sigma, St Louis, MO, USA) were added to
the bottom wells of a 48-well microchemotaxis chamber (Neu-
roprobe, Gaithersburg, MD, USA). The chambers were
inverted and incubated for 2 h (3 h when MMC was present)
in a 5% CO2 atmosphere at 37°C, allowing for cell attachment
to the membrane. Upon righting the chambers, dilutions of
synovial fluids collected from patients with RA (or control
agents) were added to the top wells and the chambers were
incubated overnight at 37°C. PBS served as a negative con-
trol, whereas recombinant human basic fibroblast growth fac-
tor (bFGF; R&D Systems, Minneapolis, MN, USA) served as a
positive control. The next morning, non-migrated cells were
detached with a cotton swab, membranes were removed, fixed
in methanol, and stained with Diff-Quik (Dade Behring, Deer-
field, IL, USA). Checkerboard analysis was performed in a sim-
ilar manner, except that the concentrations of RA SF were
varied in the upper and lower chambers. Dilutions of RA SFs
(1:100, 1:75 or 1:50) were added to the cell suspension in the
bottom wells as well as on the opposite side of the membrane,
when appropriate. Each condition was analyzed in quadrupli-
cate and migrated cells from membranes mounted on glass
slides were quantified in three representative high power
fields. Quantification of high powered fields was accom-
plished by analyzing photographs of chemotaxis spots taken
with a Nikon Coolpix E5000 (5.0 megapixel) camera mounted
on a Nikon Eclipse TS100 inverted microscope. Chemotaxis
data appeared normally distributed based on examination of
histogram plots, and statistical analysis was performed using
a Student's t-test.
To assure that local proliferation on the membrane was not
occurring, WT and p21(-/-) FLS were treated with identical con-
ditions as used for chemotaxis assays described above. Cells
were trypsinized, counted using trypan blue, plated at 2.6 ×
104 cells/well into two separate chemotaxis chambers, and
inverted to allow cell adherence to the membrane. FLS from
one chamber were fixed with MeOH exactly 2 h after plating,
allowing sufficient time for cell attachment but not enough time
for proliferation. Counts from this chamber allowed an exact
determination of the number of cells plated for each group.
WT and p21(-/-) FLS in the second chamber were plated with
or without 10 µg/ml MMC. After 2 h, the second chamber was
righted and PBS was added to the top side of all wells. After
an 18 h time period, the time allowed for migration in all chem-
otaxis experiments, the membrane was removed and the WT
and p21(-/-) FLS were fixed with MeOH and counted.Available online http://arthritis-research.com/content/8/4/R113
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Restoration of p21 expression
To restore p21 expression, p21(-/-) FLS were infected with an
adenovirus overexpressing p21 (Adp21) and compared to
mock infected WT FLS, mock infected p21(-/-) FLS or p21(-/-)
FLS infected with an adenovirus that produces an irrelevant
bacterial protein (β-galactosidase; AdlacZ). Initially, FLS
infected with Adp21 and AdlacZ were subjected to β-galac-
tosidase staining to estimate a concentration that resulted in
infection of nearly 100% of cells (1 × 1010 particles/1 × 105
cells; data not shown). All infections were completed by incu-
bation with virus for 4 h in DMEM + 5% FBS. Mock infected
WT and p21(-/-) fibroblasts were incubated with the same
media in the absence of virus. After incubation, cells were
washed three times with PBS and full growth media was
replaced for 4 h. Cells were incubated overnight in a 1:10 dilu-
tion of the full growth media. Chemotaxis assays were per-
formed as described above the following day.
Results
p21(-/-) FLS exhibit a faster growth rate than WT FLS, 
while both cell types migrate in a dose-dependent 
manner to RA SFs
Little is known about whether the reduced p21 expression
exhibited in RA FLS may be related to alterations in FLS migra-
tion. To address this issue, we isolated FLS from knee syn-
ovium of WT and p21(-/-) mice. We first assessed whether FLS
from p21(-/-) mice possessed proliferative characteristics, as
was expected from the loss of a cell cycle inhibitor. Figure 1a
demonstrates that FLS isolated from mice lacking p21 do pro-
liferate quicker than FLS isolated from WT mice. At time zero,
equal numbers of WT and p21(-/-) FLS were plated into 24-well
plates. At various time points, cell number was determined and
by 44 h after plating the cells, more p21(-/-) FLS were consist-
ently present relative to WT FLS (Figure 1a; p < 0.05). Next,
we determined whether mouse FLS would migrate in
response to human RA SF. We chose RA SF as a chemoat-
tractant for these studies because of its relevance to arthritis
and because these fluids are known to possess a combination
of biologically relevant chemoattractants at levels that are suf-
ficient to induce migration of other cell types [28]. We found
that WT (Figure 1b) and p21(-/-) (data not shown) FLS migrate
to RA SF in a dose-dependent manner. Even RA SF dilutions
of 1:1000 from some patients could significantly increase FLS
migration when compared to background migration repre-
sented by PBS (p < 0.05).
p21(-/-) FLS migrate more than WT FLS in response to RA 
SF
To directly compare migration of WT and p21(-/-)  FLS in
response to RA SF, we employed 48-well microchemotaxis
chambers and determined cell motility towards dilute RA SFs.
Cell counts were normalized to their background migration by
representing the data as fold-increase over PBS. Figure 2a
shows combined chemotaxis data analyzed from four separate
patients in three independent experiments and demonstrates
significantly more migration by the p21(-/-) FLS when com-
pared with WT FLS (p < 0.05). A representative chemotaxis
experiment is shown in Figure 2b, where RA SF was diluted
1:50 from 4 separate patients randomly designated #1 to #4.
For this assay, the PBS counts used for normalization pur-
poses were 6 for the WT FLS and 10 for the p21(-/-) FLS. The
Figure 1
p21(-/-) fibroblast-like synoviocytes (FLS) exhibit a faster growth rate  than wild-type (WT) FLS, while both cell types migrate in a dose- dependent manner to rheumatoid arthritis (RA) synovial fluids (SFs) p21(-/-) fibroblast-like synoviocytes (FLS) exhibit a faster growth rate 
than wild-type (WT) FLS, while both cell types migrate in a dose-
dependent manner to rheumatoid arthritis (RA) synovial fluids (SFs). (a) 
Equal numbers of WT or p21(-/-) FLS were plated into a 24-well plate 
and allowed to grow. At various time points, cells were removed and 
quantified as described in the Materials and methods section. Bars rep-
resent the mean of triplicate wells ± standard error (SE). An asterisk 
indicates a statistically significant difference. (b) WT FLS were tested 
for their ability to migrate to different dilutions of RA SF. The sum of 
counts from three high power fields (HPFs) was determined, and bars 
represent the mean of those sums from quadruplicate wells ± SE. An 
asterisk indicates a statistically significant increase in chemotaxis rela-
tive to background migration to PBS.Arthritis Research & Therapy    Vol 8 No 4    Woods et al.
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data shown are representative of three independent experi-
Figure 2
p21(-/-) fibroblast-like synoviocytes (FLS) migrate more than wild-type  (WT) FLS in response to rheumatoid arthritis (RA) synovial fluid (SF) p21(-/-) fibroblast-like synoviocytes (FLS) migrate more than wild-type 
(WT) FLS in response to rheumatoid arthritis (RA) synovial fluid (SF). 
WT and p21(-/-) FLS were introduced to gradients of RA SFs (diluted in 
PBS) to induce migration. Cell counts are expressed as fold-increase 
over background migration to PBS (negative control). (a) Combined 
chemotaxis data analyzed from four separate patients in three inde-
pendent experiments demonstrates significantly more migration by the 
p21(-/-) FLS compared with WT FLS (p < 0.05). (b) Representative data 
from 1 of 3 independent chemotaxis assays performed using RA SF 
diluted 1:50 from 4 separate patients randomly designated #1 to #4. 
p21(-/-) FLS migrated significantly (indicated by an asterisk) more than 
WT cells in response to all four RA SFs tested.
Figure 3
Enhanced migration of p21(-/-) fibroblast-like synoviocytes (FLS) to  rheumatoid arthritis (RA) synovial fluid (SF) is independent of cell cycle  regulation Enhanced migration of p21(-/-) fibroblast-like synoviocytes (FLS) to 
rheumatoid arthritis (RA) synovial fluid (SF) is independent of cell cycle 
regulation. (a) Wild-type (WT) and p21(-/-) FLS were treated identically 
to the chemotaxis assay in the presence and absence of mitomycin C 
(MMC) to determine whether the MMC conditions applied allowed for 
any proliferation of FLS. Cell counts are expressed as the percentage 
of cells plated, which was determined by counting the number of cells 
present after 2 h. The asterisk indicates a statistically significant differ-
ence between the groups, as determined from three identical experi-
ments. (b) WT and p21(-/-) FLS were allowed to adhere to the bottom 
side of the membrane with the chamber inverted in the presence of 10 
µg/ml MMC. Subsequently, cells were introduced to gradients of RA 
SFs diluted 1:75 to induce migration. Cell counts are expressed as 
fold-increase over background migration to PBS (negative control). An 
asterisk indicates a statistically significant difference. Combined chem-
otaxis data analyzed from seven separate patients in nine independent 
experiments demonstrates significantly more migration by the p21(-/-) 
FLS compared with WT FLS (p < 0.05). (c) A representative chemo-
taxis assay of 9 independent assays examining RA SF (1:75 dilution) 
from 7 separate patients randomly designated #5 to #11. bFGF, basic 
fibroblast growth factor.Available online http://arthritis-research.com/content/8/4/R113
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ments, which consistently suggest that p21(-/-) FLS exhibit sig-
nificantly enhanced migration towards RA SFs (p < 0.05).
Migratory differences between WT and p21(-/-) FLS are a 
mixture of chemotaxis and chemokinesis
To examine whether the increased migration of p21(-/-) FLS
may simply be the result of a non-specific enhancement of
chemokinesis, we performed several checkerboard assays. A
representative assay (Table 1) suggests that despite a minimal
increase in random migration, there is also a large increase in
specific chemotaxis when the cells are exposed to a greater
concentration of RA SF on the opposite side of the membrane.
We have previously reported a similar mixture of chemotaxis
and chemokinesis [29]. These findings suggest that loss of
p21 in FLS may enhance the cells ability to migrate towards
the proinflammatory constituents of the RA joint.
Enhanced migration of p21(-/-) FLS to RA SF is 
independent of cell cycle regulation
To examine whether the enhanced migration could be
explained by differences in proliferation, we performed chem-
otaxis assays using cells that were pretreated with MMC to
stop cell division. To assure that local proliferation on the mem-
brane was not occurring in the presence of MMC, we deter-
mined the number of WT and p21(-/-) FLS in the presence and
absence of MMC at the end of the assay and compared it with
the number of cells plated at the start of the assay. Figure 3a
shows that although FLS proliferation did appear to occur dur-
ing the 18 h period, cells treated with MMC were at or below
the number of cells plated. The number of WT FLS treated
with MMC was significantly below the number of WT FLS that
were not MMC treated (p < 0.05). Similarly, the number of
p21(-/-) FLS treated with MMC was significantly below the
number of p21(-/-) FLS that were not MMC treated (p < 0.05).
In contrast, there were no significant differences between WT
and p21(-/-) FLS that were or were not MMC treated. This sug-
gests that MMC completely halted proliferation and that any
demonstrable changes in chemotaxis in the presence of MMC
are not due to proliferation on the membrane.
Figure 3b demonstrates that when data are combined from
p21(-/-) and WT FLS chemotaxis assays using seven separate
RA SFs in nine independent experiments, there is significantly
more migration by the p21(-/-) FLS compared with WT FLS (p
< 0.05). Figure 3c shows a representative chemotaxis assay
that employed RA SFs from seven different patients. For this
assay, the PBS counts used for normalization purposes were
61 for the WT FLS and 45 for the p21(-/-) FLS. It should be
noted that the counts in chemotaxis assays using mouse FLS
isolated on different dates occasionally varied greatly between
experiments (background migration as well as induced migra-
tion), although the trend was always identical, such that the
p21(-/-) FLS migrated significantly more than the WT FLS.
Therefore, in the presence of MMC, a cell division inhibitor, we
still demonstrate that loss of p21 confers an increased migra-
tory behavior on FLS when compared with WT cells (p <
0.05). Of note in Figure 3c, we included migration towards 1
nM bFGF, a factor known to induce migration of fibroblasts.
Indeed, bFGF induced a two- to three-fold increase in cell
migration over PBS values, although this migration displayed
no significant differences between WT and p21(-/-) FLS.
WT and p21(-/-) FLS exhibit no differences in migration to 
bFGF
To begin to assess whether the enhanced migration may
exhibit specificity with regards to the chemoattractant used,
we performed several chemotaxis assays using bFGF as the
chemoattractant. Figure 4 shows that when we used bFGF as
a sole chemoattractant (representative of seven independent
chemotaxis assays), we did not see consistent differences
between migration of p21(-/-) and WT fibroblasts. Therefore,
the enhanced migration may be specific for another chemoat-
Table 1
Migratory differences between wild-type and p21(-/-) fibroblast-like synoviocytes are due to altered chemotaxis and chemokinesis
RA SF dilution across membrane
RA SF dilution in lower 
wells
None 1:100 1:75 1:50
None 3 ± 0.9 142 ± 9 156 ± 11 194 ± 9
1:100 16 ± 3 133 ± 8 122 ± 5 185 ± 13
1:75 18 ± 2 92 ± 3 143 ± 7 209 ± 7
1:50 12 ± 2 116 ± 8 100 ± 4 130 ± 9
Checkerboard assay results of p21(-/-) fibroblast-like synoviocytes (FLS) migration are presented such that dilutions of rheumatoid arthritis (RA) 
synovial fluids (SFs), which were included with the cells (in the lower wells), are displayed down the left hand column. Dilutions of RA SFs across 
the membrane from the cells are displayed in the top row. Numbers represent the sum of counts from three high power fields determined from 
quadruplicate wells ± standard error (SE). These data are representative of three independent checkerboard assays.Arthritis Research & Therapy    Vol 8 No 4    Woods et al.
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tractant, or a combination of chemoattractants found in the RA
SF.
Restoration of p21 in p21(-/-) FLS significantly reduces 
excessive migration to RA SF
We next aimed to use an adenovirus to increase p21 and
establish whether reconstituting p21(-/-) FLS with p21 would
reduce their excessive migration. First, to demonstrate that our
adenoviral construct produced functional p21, we infected
p21(-/-) FLS and compared the growth rate with that of p21(-/-)
FLS infected with an adenovirus producing green fluorescent
protein. Growth of FLS expressing p21 was significantly inhib-
ited compared with FLS expressing green fluorescent protein
(p < 0.05; data not shown). Next, to establish whether p21 is
solely responsible for the enhanced migratory characteristics,
we reconstituted p21(-/-) FLS with p21 and compared chemo-
taxis to cells infected with AdlacZ. Figure 5 demonstrates that
the migration of p21(-/-) FLS infected with Adp21 was compa-
rable to WT FLS that were mock-infected. This migration was
significantly below mock-infected p21(-/-)  FLS or those
infected with an adenovirus producing an irrelevant bacterial
protein, β-galactosidase.
Discussion
Expression of p21 in RA synovial tissue is significantly
decreased when compared with the same tissue from osteoar-
thritis patients. Expression of p21 inversely correlates with
thickness of the RA synovial lining [20]. Similarly, FLS isolated
from RA patients express significantly less p21 than FLS iso-
lated from osteoarthritis patients. Little is known, however,
about whether the reduced p21 expression found in RA FLS
may be related to alterations in FLS migration. As a constituent
of the synovial pannus in RA, FLS have long been identified as
key players in the aggressive invasion of cartilage and bone,
contributing to joint damage [30]. To address the issue of
whether the lack of p21 in RA FLS may alter the migratory
properties of these cells, we isolated FLS from knee synovium
of WT and p21(-/-) mice. We first assessed whether FLS from
p21(-/-) mice possessed proliferative characteristics, as was
expected from the loss of a cell cycle inhibitor. Figure 1a dem-
onstrates that FLS isolated from mice lacking the cell cycle
inhibitor p21 do indeed multiply quicker than FLS isolated
from WT mice. Next, we demonstrated that mouse FLS
migrate in a dose-dependent manner to human RA SF. We
chose RA SF as a chemoattractant for these studies because
of its relevance to arthritis, where RA FLS express significantly
less p21, in addition to the fact that these fluids are known to
possess a combination of biologically relevant chemoattract-
ants at levels that are sufficient to induce migration [28].
A direct comparison of WT and p21(-/-) FLS migration to RA SF
suggests that p21(-/-) FLS exhibit significantly enhanced migra-
tion (p < 0.05). Our checkerboard assays (Table 1) suggest
that this may be a mixed combination of mainly chemotaxis
with some chemokinesis. Use of MMC to inhibit the cell cycle
completely halted proliferation of both cell types on the chem-
otaxis membrane. While Figure 1a clearly demonstrates that
Figure 4
Wild-type (WT) and p21(-/-) fibroblast-like synoviocytes (FLS) exhibit no  differences in migration when basic fibroblast growth factor (bFGF) is  used as the chemoattractant Wild-type (WT) and p21(-/-) fibroblast-like synoviocytes (FLS) exhibit no 
differences in migration when basic fibroblast growth factor (bFGF) is 
used as the chemoattractant. Migratory differences between WT and 
p21(-/-) FLS were assessed using various concentrations of bFGF as 
the chemoattractant. Cell counts are expressed as fold-increase over 
background migration to PBS (negative control). Results are represent-
ative of seven independent assays. KO, knockout.
Figure 5
Restoration of p21 in p21(-/-) fibroblast-like synoviocytes (FLS) signifi- cantly reduces excessive migration to rheumatoid arthritis (RA) synovial  fluid (SF) Restoration of p21 in p21(-/-) fibroblast-like synoviocytes (FLS) signifi-
cantly reduces excessive migration to rheumatoid arthritis (RA) synovial 
fluid (SF). Cells were infected as described and used for chemotaxis 
the following day, when nearly all FLS were estimated to express their 
recipient transgene. Three high powered fields (HPFs) of migrated cells 
were counted and their sum was determined for each well. Bars repre-
sent the mean of quadruplicate wells ± standard error (SE) and an 
asterisk indicates a statistically significant difference. These data are 
representative of three independent assays. AdlacZ, adenovirus 
expressing β-galactosidase; Adp21, adenovirus expressing p21; WT, 
wild type.Available online http://arthritis-research.com/content/8/4/R113
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p21(-/-) FLS proliferate quicker than WT FLS, the non-MMC
treated FLS in Figure 3a did not show this trend, most likely
due to significant differences in the design of these two exper-
iments. For example, the FLS used for Figure 1 had access to
10% serum continuously while growing on non-coated plates,
while FLS used for Figure 3a had 1% serum for 18 h and then
0.1% serum for the last hour before being plated onto a gelatin
coated membrane. It is possible that these differences in
experimental design masked the growth difference between
the two cell types in this shortened time frame. Also, a compar-
ison of the representative assay shown in Figure 2b with that
shown in Figure 3c should not suggest that migration in the
absence of MMC was greater than migration in the presence
of MMC. The increased migration relative to PBS varied
greatly when comparing FLS that were isolated from pooled
mouse knees on different dates. However, the trend was
always consistent, such that the FLS from p21(-/-)  mice
migrated more than those from WT mice. Overall, chemotaxis
assays performed in the presence of a cell cycle inhibitor sug-
gest that the changes noted are not the result of enhanced
proliferation by migrating cells. Moreover, reconstitution of
p21 into p21(-/-) FLS is sufficient to significantly reduce migra-
tion of these cells, suggesting that the loss of p21 in FLS may
enhance their ability to migrate towards the proinflammatory
constituents of the RA joint.
Recently, Besson and coworkers [17] demonstrated that p27,
a cell cycle inhibitor with high homology to p21, also plays a
role in regulating cell migration. While our data suggest that
FLS lacking p21 have enhanced migratory ability, this recent
study reports that murine embryonic fibroblasts lacking p27
exhibit a dramatic decrease in cell motility, the exact opposite
response, in a cell-cycle independent manner. p21(-/-) embry-
onic fibroblasts were also examined in this study, but were
determined to not exhibit differences in migration when com-
pared with WT cells [17]. There are several major differences
between the designs of our studies, which likely account for
the novel results that we are reporting with p21. For example,
our study included p21(-/-) fibroblasts that were isolated from
synovium obtained from 5–8 week old mice, whereas the pre-
vious study employed fibroblasts derived from an embryo. The
previous study examined cell migration by wounding of a con-
fluent monolayer of cells, whereas our study examined specific
directed chemotaxis and chemokinesis. An additional key dif-
ference is that our study used RA SF as the chemoattractant
to assess whether the multiple biological constituents of these
disease-related fluids may display differences in chemoattrac-
tion between p21(-/-) and WT fibroblasts. In fact, when we uti-
lized bFGF as a sole chemoattractant in seven independent
chemotaxis assays, we do not see consistent differences
between migration of p21(-/-) and WT fibroblasts, which is in-
line with the previously published findings where p21(-/-)
assays were performed in the presence of growth serum [17].
Previous studies in vascular smooth muscle cells (VSMCs)
involving the homeobox transcription factor growth-arrest spe-
cific homeobox (Gax) have also established a tie between p21
and cell migration [31]. Overexpression of Gax in VSMCs has
an antiproliferative effect induced by the upregulation of p21
[32]. Moreover, transduction of Gax cDNA inhibits VSMC
migration to a variety of chemoattractants, an effect that is lost
when attempted in p21(-/-) VSMCs [31]. Upon restoring p21(-/
-) cells with exogenous p21, transduction of Gax cDNA once
again inhibits VSMC migration. Thus, increasing Gax upregu-
lates p21 and inhibits VSMC migration. This appears consist-
ent with our studies, in which a loss of p21 in FLS results in
excessive migration and reconstituting p21 is capable of
reducing the exuberant migration to RA SF. Overexpressing
p21 alone in WT VSMCs did not influence cell migration. In
our hands, similarly, infecting WT FLS with a high titer of
Adp21 did not inhibit cell migration to RA SF (data not shown).
FLS locomotion can be regarded as an important pathogenic
mechanism contributing to the invasion of cartilage and bone
in RA. Grafting of RA FLS alone to SCID mice, in the absence
of a functional immune system, results in chronic arthritis,
underscoring the potential key role of these cells in driving dis-
ease [19,33]. This is an area of intense research interest,
where invasiveness of RA FLS in vitro has recently been asso-
ciated with the rate of joint destruction in vivo [34]. Invasive-
ness of RA FLS varies on a patient-by-patient basis [34], and
these same RA FLS have been shown to express significantly
lowered levels of p21 [20]. We demonstrate that the loss of
p21 in FLS results in a significant increase in migration
towards the combination of biologically relevant chemoattract-
ants found in multiple RA SFs. In addition, this effect is inde-
pendent of the cell cycle activity of p21, and restoring p21 can
reconstitute migration to levels comparable to WT cells. These
findings, in combination with previous studies performed in
VSMCs, suggest that p21 may be a key regulator of cellular
migration, with particular importance to RA.
Conclusion
We previously demonstrated that RA FLS exhibit decreased
expression of p21, and now observe that a lack of p21 may
contribute to excessive migration of FLS. These data suggest
that p21 plays a novel role in normal FLS in repression of
migration. Further, a lack of p21 expression, as occurs in RA
FLS, may contribute to excessive invasion towards the biolog-
ical chemoattractants found in RA SF.
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